ORGANIZATION, EXPERIENCE OF OBSERVATION AND TREATMENT OF PREMATURE INFANTS IN THE Fyodorov Eye Microsurgery Federal State Institution of Minzdrav of Russia, Novosibirsk Branch
https://doi.org/10.15372/SSMJ20190218
Abstract
Purpose – to analyze the effectiveness of the algorithm used to monitor and treat premature infants. Material and methods. 903 premature babies were under the supervision of ophthalmologists from our clinic over the past 4 years (2014–2017). Retinopathy of prematurity was revealed in 302 patients. The laser photocoagulation was required in 78 cases. Repeated interventions were performed in 13 patients. Induced regression of the disease occurred in 72 children. The development of the 4–5 stage of the active phase of retinopathy of prematurity occurred in 6 patients. In 4 cases, the development of the 4–5 stage of the active phase of retinopathy of prematurity occurred in the case of posterior aggressive retinopathy. Results and discussion. The teamwork of ophthalmologists and neonatologists, timely and complete examination, reveals early signs of retinopathy of prematurity. Timely laser photocoagulation reduces the risk of disability, development of blindness and low vision. Reducing the number of laser photocoagulation carried out with an unchanged number of examinations, a low number of patients with terminal stages of the disease testify to the high effectiveness of monitoring and treatment of children with retinopathy of prematurity.
About the Authors
K. A. Belousova
S. Fyodorov Eye Microsurgery Federal State Institution of Minzdrav of Russia, Novosibirsk Branch
Russian Federation
Russian Federation
ophthalmologist
630071, Novosibirsk, Kolkhidskaya str., 10
D. R. Mamulat
S. Fyodorov Eye Microsurgery Federal State Institution of Minzdrav of Russia, Novosibirsk Branch
Russian Federation
Russian Federation
ophthalmologist
630071, Novosibirsk, Kolkhidskaya str., 10
M. A. Sharokhin
S. Fyodorov Eye Microsurgery Federal State Institution of Minzdrav of Russia, Novosibirsk Branch
Russian Federation
Russian Federation
ophthalmologist
630071, Novosibirsk, Kolkhidskaya str., 10
I. L. Plisov
S. Fyodorov Eye Microsurgery Federal State Institution of Minzdrav of Russia, Novosibirsk Branch
Russian Federation
Russian Federation
doctor of medical sciences, head of the 3rd ophthalmology department
630071, Novosibirsk, Kolkhidskaya str., 10
N. G. Antsiferova
S. Fyodorov Eye Microsurgery Federal State Institution of Minzdrav of Russia, Novosibirsk Branch
Russian Federation
Russian Federation
candidate of medical sciences, ophthalmologist
630071, Novosibirsk, Kolkhidskaya str., 10
V. V. Solov'yova
S. Fyodorov Eye Microsurgery Federal State Institution of Minzdrav of Russia, Novosibirsk Branch
Russian Federation
Russian Federation
pediatrician
630071, Novosibirsk, Kolkhidskaya str., 10
References
1. Катаргина Л.А. Ретинопатия недоношенных, современное состояние проблемы и задачи организации офтальмологической помощи детям в РФ // Рос. педиатр. офтальмология. 2012. (1). 5–7.
2. Либман Е.С., Шахова Е.С. Слепота и инвалидность вследствие патологии органа зрения в России // Вестн. офтальмологии. 2006. (1). 35–37.
3. Нероев В.В., Тарутта Е.П., Катаргина Л.А., Шамшинова А.М. Избранные лекции по детской офтальмологии. М.: ГЭОТАР-Медиа, 2009. 38 с.
4. Сайдашева Э.И., Сомов Е.Е., Фомина Н.В. Избранные лекции по неонатальной офтальмологии. СПб.: Нестор-История, 2006. 272 с.
5. Терещенко А.В., Белый Ю.А., Трифаненкова И.Г. Ранняя диагностика и мониторинг ретинопатии недоношенных. Калуга: Столичный бизнес, 2008. 84 с.
6. Austeng D., Källen K.B., Hellström A., Jakobsson P.G., Johansson K., Tornqvist K., Wallin A., Holmström G.E. Screening for retinopathy of prematurity in infants born before 27 weeks’ gestation in Sweden // Arch. Ophthalmol. 2011. 129. 167–172.
7. Binenbaum G., Tomlinson L. Postnatal growth and retinopathy of prematurity study: Rationale, design, and subject characteristics // Ophthalm. Epidem. 2017. 24. (1). 36–47.
8. Campbell J.P., Ataer-Cansizoglu E., Bolon-Canedo V., Bozkurt A., Erdogmus D., Kalpathy-Cramer J., Patel S.N., Reynolds J.D., Horowitz J., Hutcheson K., Shapiro M., Repka M.X., Ferrone P., Drenser K., Martinez-Castellanos M.A., Ostmo S., Jonas K., Chan R.V., Chiang M.F. Expert diagnosis of plus disease in retinopathy of prematurity from computer-based image analysis // JAMA Ophthalmol. 2016. 134. (6). 651–657.
9. Darlow B.A., Ells A.L., Gilbert C.E., Gole G.A., Quinn G.E. Are we there yet? Bevacizumab therapy for retinopathy of prematurity // Arch. Dis. Child. Fetal. Neonatal. 2013. 98. (2). 170–174.
10. Fleck B.W., Williams C., Juszczak E., Cocker K., Stenson B.J., Darlow B.A., Dai S., Gole G.A., Quinn G.E., Wallace D.K., Ells A., Carden S., Butler L., Clark D., Elder J., Wilson C., Biswas S., Shafiq A., King A., Brocklehurst P., Fielder A.R. An international comparison of retinopathy of prematurity grading performance within the benefits of oxygen saturation targeting II trials // Eye. 2018. 32. (1). 74–80.
11. Harder B.C., Schlichtenbrede F.C., von Baltz S., Jendritza W., Jendritza B., Jonas J.B. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results // Am. J. Ophthalmol. 2013. 155. 1119–1124.
12. Hurley B.R., McNamara J.A., Fineman M.S., Ho A.C., Tasman W., Kaiser R.S., Vander J.F., Regillo C.D., Brown G.C. Laser treatment for ROP: Evolution in treatment technique over 15 years // Retina. 2006. 26. 16–17.
13. Hwang C.K., Hubbard G.B., Hutchinson A.K., Lambert S.R. Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: A 5-year retrospective analysis // Ophthalmology. 2015. 122. (5).1008–1015.
14. Issac M., Mireskandari K., Tehrani N. Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser // JAAPOS. 2015. 19. 140–144.
15. Lad E.M., Nguyen T.C., Morton J.M., Moshfeghi D.M. Retinopathy of prematurity in the United States // Br. J. Ophthalmol. 2008. 92. 320–325.
16. Morin J., Luu T.M., Superstein R., Ospina L.H., Lefebvre F., Simard M.N., Shah V., Shah P.S., Kelly E.N. Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity // Pediatrics. 2016. 137. (4). 96–101.
17. Toy B.C., Schachar I.H., Tan G.S.W., Moshfeghi D.M. Chronic vascular arrest as a predictor of bevacizumab treatment failure in retinopathy of prematurity // Ophthalmology. 2016. 123. (10). 2166–2175.
18. VanderVeen D.K., Coats D.K., Dobson V., Fredrick D., Gordon R.A., Hardy R.J., Neely D.E., Palmer E.A., Steidl S.M., Tung B., Good W.V. Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study // Arch. Ophthalmol. 2006. 124. 766–773.
19. Vinekar A., Dogra M.R., Sangtam T., Narang A., Gupta A. Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: Ten year data from a tertiary care center in a developing country // Indian J. Ophthalmol. 2007. 55. 331–336.
20. Wheeler D.T., Dobson V., Chiang M.F., Bremer D.L., Gewolb I.H., Phelps D.L., Hardy R.J., Good W.V., Fellows R., Tung B.P., Palmer E.A. Retinopathy of prematurity in infants weighing less than 500 grams at birth enrolled in the early treatment for retinopathy of prematurity study // Ophthalmology. 2011. 118. 1145–1151.
21. Wittenberg L.A., Jonsson N.J., Paul Chan R.V., Chiang M.F. Computer-based image analysis for plus disease diagnosis in retinopathy of prematurity // J. Pediatr. Ophthalmol. Strabismus. 2011. 49. (1). 1–19.
22. Wu W.C., Lien R., Liao P.J., Wang N.K., Chen Y.P., Chao A.N., Chen K.J., Chen T.L., Hwang Y.S., Lai C.C. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity // JAMA Ophthalmol. 2015. 133. (4). 391–397.
Review
For citations:
Belousova K.A., Mamulat D.R., Sharokhin M.A., Plisov I.L., Antsiferova N.G., Solov'yova V.V. ORGANIZATION, EXPERIENCE OF OBSERVATION AND TREATMENT OF PREMATURE INFANTS IN THE Fyodorov Eye Microsurgery Federal State Institution of Minzdrav of Russia, Novosibirsk Branch. Сибирский научный медицинский журнал. 2019;39(2):124-129. (In Russ.) https://doi.org/10.15372/SSMJ20190218
Views:
254
Email this article 